| Title | A Phase 1b/2, Open-Label, Dose Escalation Study to Evaluate the Safety, Pharmacokinetics, and Efficacy of SM88 in Patients With Prostate Cancer |
|---|---|
| Disease/Condition | Prostate Cancer,Oncology (Medical/Hematologic),Urologic Oncology (Med Onc),Neoplasms,Urogenital Neoplasms |
| Description | |
| Eligibility Criteria | Click here for eligibility requirements |
| Principal Investigator | Benjamin Gartrell, MD |
| Contact Name | Gina Aracena |
| Contact Email | gihernan@montefiore.org |
| Protocol Number | 18-06-199-01 |
| Inclusion/Notes | This Information was obtained from ClinicalTrials.gov |
| Status | Active/Enrolling |
| Adult Clinical Trial | Yes |
| Pediatric Clinical Trial | No |
| Sub-Specialty | Medical and Hematologic Oncology - Prostate |
| Adult, Pediatric, Both | Adult |